AT-Patch (ATP-C130/ATP-C70) vs V7 Diagnostic Ultrasound System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AT-Patch (ATP-C130/ATP-C70)

by ATsens Co.

V7 Diagnostic Ultrasound System

by Samsung Medison Co.

AI Verdict

Tool A, AT-Patch, is a wearable ECG monitor designed for continuous cardiac monitoring and arrhythmia detection through AI-powered analysis of ECG data. Tool B, the Samsung V7 Diagnostic Ultrasound System, is a versatile ultrasound machine that uses AI for advanced imaging and diagnostic capabilities across various specialties, including cardiovascular. While both tools utilize AI in cardiology, their core functionalities and deployment methods are distinct, with AT-Patch focusing on long-term ECG data collection and analysis, and the V7 on real-time diagnostic imaging.

Choose AT-Patch (ATP-C130/ATP-C70) if…

Choose AT-Patch if you need long-term, continuous cardiac monitoring for patients experiencing intermittent symptoms like palpitations, dizziness, or fatigue, where a wearable, shower-proof device with up to 14 days of monitoring is beneficial. Its integrated AI-powered analysis software is ideal for enhancing arrhythmia detection and providing comprehensive ECG reports for diagnosis and management of heart conditions.

View AT-Patch (ATP-C130/ATP-C70) →

Choose V7 Diagnostic Ultrasound System if…

Choose the Samsung V7 Diagnostic Ultrasound System if you require a versatile, high-performance imaging solution for a wide range of clinical applications, particularly in women's health, general imaging, and cardiovascular assessments. Its AI-powered Intelligent Assist features, such as BiometryAssist™ for fetal measurements and UterineAssist™ for uterine analysis, make it ideal for enhancing diagnostic precision and workflow efficiency in complex cases.

View V7 Diagnostic Ultrasound System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AT-Patch (ATP-C130/ATP-C70)	V7 Diagnostic Ultrasound System
Pricing	N/a	Contact for pricing
Deployment	Wearable device for patients; analysis software deployed on-premise at medical institutions.	On-premise (hardware)
FDA Status	1 AI-estimated	1 AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AT-Patch (ATP-C130/ATP-C70)

AT-Patch is designed for patient comfort and ease of use, being compact, lightweight (13g), shower-proof, and requiring no charging or electrode replacement during up to 14 days of monitoring. The AT-Note smartphone app allows for live ECG viewing and symptom recording, further enhancing patient-side usability. In contrast, the Samsung V7 is an on-premise ultrasound system, and while it features a streamlined user interface and intelligent assist features for clinicians, its inherent nature as a complex diagnostic imaging system makes it less 'usable' in the general sense compared to a wearable patient device.

Clinical Value

V7 Diagnostic Ultrasound System

The Samsung V7 offers a wide range of AI-powered diagnostic features across multiple specialties including women's health, general imaging, and cardiovascular applications, such as automated fetal biometry, fetal heart evaluation, uterine measurements, and tissue stiffness assessment. This broad and deep diagnostic capability provides significant clinical value. While AT-Patch offers continuous ECG monitoring and AI-powered arrhythmia detection, its clinical scope is more focused on cardiac rhythm analysis.

Pricing & Value

Tie

Neither company provides public pricing details for their products, making a direct comparison of pricing and value difficult. Both products are advanced medical devices with specialized applications, suggesting a significant investment for healthcare institutions. Without transparent pricing, it's impossible to definitively declare a winner in this dimension.

Enterprise Readiness

V7 Diagnostic Ultrasound System

The Samsung V7, as a high-performance diagnostic ultrasound system, is designed for integration into hospital departments and busy ultrasound environments, with features aimed at streamlining workflow and enhancing efficiency for imaging professionals. Its on-premise hardware deployment and comprehensive diagnostic capabilities suggest a robust solution for enterprise-level clinical use. AT-Patch, while valuable for remote monitoring, is a patient-worn device with analysis software deployed on-premise, which may require different considerations for large-scale enterprise integration compared to a dedicated imaging system.

Innovation

V7 Diagnostic Ultrasound System

The Samsung V7 showcases significant innovation with its 'Crystal Architecture' for enhanced imaging and a wide array of AI-powered intelligent assist features like BiometryAssist, 5D Heart Color, and UterineAssist, which automate complex measurements and improve diagnostic precision across various specialties. While AT-Patch utilizes AI for ECG analysis and offers a convenient wearable design, the breadth and depth of AI-driven diagnostic advancements in the V7 appear more extensive.

Support & Docs

V7 Diagnostic Ultrasound System

Samsung, as a large global corporation, generally offers extensive support resources, including online support, live chat, text, email, and face-to-face support through service centers, along with warranty information and replacement parts. While AT-Patch provides user manuals and an app, the overall support infrastructure of a large company like Samsung is likely more comprehensive and readily available for a complex medical system.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AT-Patch (ATP-C130/ATP-C70)	V7 Diagnostic Ultrasound System
Name	AT-Patch (ATP-C130/ATP-C70)	V7 Diagnostic Ultrasound System
Description	FDA-cleared wearable ECG monitor offering up to 14 days of continuous cardiac monitoring with high accuracy, a shower-proof design, and integrated AI-powered analysis software for enhanced arrhythmia detection.	High-performance, versatile ultrasound scanner featuring AI-powered tools and advanced imaging technology for superior diagnostic capabilities across women's health, general imaging, and cardiovascular applications.
Company	ATsens Co.	Samsung Medison Co.
Tagline	Ambulatory ECG Monitor for Continuous Cardiac Monitoring	Performance Meets Versatility
Categories	Cardiology AI, Wearables & Remote Monitoring (RPM)	Cardiology AI, OB/GYN AI, Radiology & Imaging AI
Key Features	Up to 14 days of continuous ECG monitoring (ATP-C130), High-performance sensor chip for accurate ECG signal acquisition, Short-length electrode to minimize motion artifact noise, Shower-proof design (IP57 for ATP-C130, IP44 for ATP-C70), No charging or electrode replacement required during monitoring, Compact and lightweight (13g) for patient comfort, AT-Note smartphone app for live ECG viewing and symptom recording, AT-Report software with AI/machine learning algorithms for ECG analysis	Crystal Architectureu2122 (CrystalBeamu2122, CrystalLiveu2122) for enhanced 2D, 3D, and color imaging, AI-Powered Intelligent Assist features for diagnostic precision and workflow efficiency, BiometryAssistu2122 for automated fetal biometry measurements, 5D Heart Coloru2122 for semi-automated fetal heart evaluation, UterineAssistu2122 for automated uterine size and shape measurements using Deep Learning, S-Shearwave Imagingu2122 for quantitative, non-invasive assessment of tissue stiffness (e.g., breast, liver), ShadowHDRu2122 for improved visualization in shadowed regions, MV-Flowu2122 for detailed visualization of microvascular perfusion

Videos

Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and V7 Diagnostic Ultrasound System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

The AT-Patch is a wearable device for patients, with analysis software deployed on-premise at medical institutions, suggesting a workflow where ECG data is collected by the patch and then analyzed using dedicated software. The Samsung V7 ultrasound system is an on-premise hardware solution that enhances workflow through features like SonoSyncu2122 for real-time image sharing and collaboration, and TouchEdit for customizing the touchscreen interface. The V7 can export images and videos in various formats and connects to hospital networks, which facilitates integration with existing systems.

What is the accuracy and sensitivity of each tool's AI-powered analysis for relevant clinical conditions?

The AT-Patch has demonstrated high accuracy in detecting arrhythmias, with one study showing 99.6% accuracy in locating abnormal electrical wavefront positions and 83.5% accuracy in estimating heart attack risk based on various vital signs. For the Samsung V7, AI-powered features like BiometryAssistu2122 automate fetal biometry measurements for accuracy, and UterineAssistu2122 automatically measures uterine size and shape using deep learning. S-Shearwave Imagingu2122 provides quantitative, non-invasive assessment of tissue stiffness, aiding in accurate diagnosis.

Which specialties are these tools best suited for, and what specific clinical contexts would drive the choice between them?

The AT-Patch is primarily suited for cardiology, family medicine, and internal medicine, focusing on continuous cardiac monitoring and arrhythmia detection. The Samsung V7 is a versatile diagnostic ultrasound system ideal for cardiology, obstetrics & gynecology, and radiology, offering advanced imaging and AI tools for a wide range of applications including fetal assessment, women's health, and general imaging. A physician would choose the AT-Patch for ambulatory cardiac monitoring, while the V7 would be selected for detailed diagnostic imaging across multiple specialties.

What is the typical learning curve for physicians and sonographers to effectively use these tools?

While specific learning curve data isn't provided for the AT-Patch, its wearable nature and smartphone app suggest a user-friendly patient experience, with the complexity likely residing in the analysis software for physicians. For the Samsung V7, user testimonials indicate it is intuitive and easy to operate, even for those unfamiliar with Samsung ultrasound systems. Its ergonomic design, responsive touch interface, and customizable workflow features like EzExam+u2122 and EzCompareu2122 are designed to minimize steps and keystrokes, enhancing ease of use.

What kind of customer support and training are available for these tools?

For the Samsung V7, support includes warranty information, face-to-face support at authorized service centers, and various contact options like live chat, email, and WhatsApp. Training is also included with the Samsung V7. While specific details for AT-Patch support are not provided, companies offering FDA-cleared medical devices typically provide support and training to medical institutions.

What audit-trail features are available to ensure data integrity and accountability?

The provided information does not explicitly detail audit-trail features for either the AT-Patch or the Samsung V7. However, given their operation within healthcare systems and handling of patient data, it is generally expected that such medical devices would incorporate features to ensure data integrity and accountability.

What are the considerations for rolling out these tools across multiple clinical sites or a large healthcare system?

For the AT-Patch, multi-site rollout would involve distributing wearable devices to patients and deploying the analysis software on-premise at each medical institution. For the Samsung V7, its compact and lightweight design with battery support makes it suitable for mobile diagnostics and various medical settings, which could facilitate multi-site deployment. Features like SonoSyncu2122 for real-time image sharing could also support remote collaboration across different sites.